Teva Pharmaceutical Industries Total Liabilities 2010-2024 | TEVA

Teva Pharmaceutical Industries total liabilities for the quarter ending September 30, 2024 were $35.375B, a 2.31% increase year-over-year.

  • Teva Pharmaceutical Industries total liabilities for 2023 were $35.353B, a 0.17% decline from 2022.
  • Teva Pharmaceutical Industries total liabilities for 2022 were $35.413B, a 2.77% decline from 2021.
  • Teva Pharmaceutical Industries total liabilities for 2021 were $36.422B, a 7.98% decline from 2020.

Teva Pharmaceutical Industries Total Liabilities 2010-2024 | TEVA

  • Teva Pharmaceutical Industries total liabilities for 2023 were $35.353B, a 0.17% decline from 2022.
  • Teva Pharmaceutical Industries total liabilities for 2022 were $35.413B, a 2.77% decline from 2021.
  • Teva Pharmaceutical Industries total liabilities for 2021 were $36.422B, a 7.98% decline from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M